“…,apixaban has been proven … compared to vitamin K antagonists, even in those with renal impairment.2,3 It is thus not surprising that apixaban has become more widely prescribed, … We are not implying that only 1 non–vitamin K antagonist oral anticoagulant should be exclusively used in the elderly.”